2026-09-28 — Insider/takeover filing: Sanofi India Limited has informed the Exchange regarding Disclosure received by the Company on 25th September 2026 under Regulation 7(2)(a) of the SEBI (Prohibition of Insider Trading) Regulations, 20 · filing(disclosure filed — the preview doesn't state buy or sell; open the filing)
2026-09-28 — Insider/takeover filing: Sanofi India Limited has informed the Exchange regarding 'Disclosure Under Regulation 7(2)(B) Of The SEBI (Prohibition Of Insider Trading) Regulations, 2015'. · filing(disclosure filed — the preview doesn't state buy or sell; open the filing)
2026-09-28 — Insider/takeover filing: Sanofi Healthcare India Private Limited has submitted to the Exchange a copy of Disclosures under Regulation 10(6)-Report to stock Exchange in respect of any acquisition made in reliance upon exemptio · filing(disclosure filed — the preview doesn't state buy or sell; open the filing)
2026-09-17 — Insider/takeover filing: Sanofi Healthcare India Private Limited has Submitted to the Exchange a copy of Disclosure under Regulation 10 (5) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and · filing(disclosure filed — the preview doesn't state buy or sell; open the filing)
Filed with the exchange under SEBI disclosure rules. Shown alongside the deal tape above so both public streams sit on one page — an overlap is an observation, never a prediction.